U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
186871186871ADNI: Alzheimer's Disease Neuroimaging InitiativeCompletedNo Results AvailableAlzheimer's DiseaseProcedure: Magnetic Resonance Imaging (MRI)|Procedure: Positron Emission Tomography (PET)|Procedure: Lumbar Puncture (LP)https://ClinicalTrials.gov/show/NCT00106899
186872186872HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)Active, not recruitingNo Results AvailableCardiovascular Disease|Myocardial Infarction|Stroke|CancerDrug: Folic acid, vitamin B6 and B12 or placebohttps://ClinicalTrials.gov/show/NCT00106886
186873186873A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety DisorderCompletedNo Results AvailableAnxiety DisorderDrug: a benzodiazepine drughttps://ClinicalTrials.gov/show/NCT00106860
186874186874A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type PsoriasisCompletedNo Results AvailablePsoriasis|ParapsoriasisDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT00106847
186875186875A Study of the Safety and Efficacy of Infliximab in Patients With PsoriasisCompletedNo Results AvailablePsoriasisDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT00106834
186876186876Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Tiotropium Bromide Inhalation Powderhttps://ClinicalTrials.gov/show/NCT00106821
186877186877Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Muraglitazar|Drug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT00106808
186878186878Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDSCompletedNo Results AvailableHIV Infections|Fatigue|HIV Positive|AIDS|Healthy Volunteer|HVhttps://ClinicalTrials.gov/show/NCT00106795
186879186879Transcranial Electrical Polarization to Treat Focal Hand DystoniaCompletedNo Results AvailableDystonia|Focal Hand Dystonia|FHDProcedure: Transcranial Electrical Polarization (TEP)https://ClinicalTrials.gov/show/NCT00106782
186880186880Vaccine to Prevent West Nile Virus DiseaseCompletedNo Results AvailableHealthy|West Nile Fever|Healthy Volunteer|HVDrug: VRC-WNVDNA017-00-VPhttps://ClinicalTrials.gov/show/NCT00106769
186881186881Clinical and Genetic Studies of Familial Exudative VitreoretinopathyCompletedNo Results AvailableExudatiaon|Avascular Retina|Retina Fold|Eye Diseases|Familial Exudative Vitreoretinopathy|FEVRhttps://ClinicalTrials.gov/show/NCT00106756
186882186882Natural History and Genetic Studies of Usher SyndromeActive, not recruitingNo Results AvailableRetinitis Pigmentosa Syndromic|Congenital Deafness|Usher Syndrome|Retinitis Pigmentosa and Deafness|Retinitis Pigmentosahttps://ClinicalTrials.gov/show/NCT00106743
186883186883Effectiveness of Narrative Medicine on Pain Intensity and Quality of LifeCompletedNo Results AvailableCancerProcedure: Narrative medicinehttps://ClinicalTrials.gov/show/NCT00106717
186884186884Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Comparator: Sitagliptin|Drug: Comparator: Placebo|Drug: Comparator: Pioglitazonehttps://ClinicalTrials.gov/show/NCT00106704
186885186885Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)CompletedNo Results AvailablePreneoplastic Conditions|Prostatic Intraepithelial NeoplasiaDrug: Toremifene 20 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00106691
186886186886Typology of Adherence in Adolescents: Phase IICompletedNo Results AvailableHIV Infectionhttps://ClinicalTrials.gov/show/NCT00106678
186887186887New Onset Weakness in Critically Ill Patients and the Risk of Death and Recurrent ICU AdmissionCompletedNo Results AvailableMuscle Weakness|Critical Illnesshttps://ClinicalTrials.gov/show/NCT00106665
186888186888Childhood Autism Risks From Genetics and the Environment (The CHARGE Study)Active, not recruitingNo Results AvailableAutism|Developmental Disabilitieshttps://ClinicalTrials.gov/show/NCT00106652
186889186889A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant PatientsCompletedHas ResultsKidney TransplantationDrug: CP-690,550|Drug: CP-690,550|Drug: tacrolimushttps://ClinicalTrials.gov/show/NCT00106639
186890186890Suberoylanilide Hydroxamic Acid in Advanced Solid TumorsCompletedHas ResultsAdvanced CancerDrug: vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]) in combination with Pemetrexed and Cisplatinhttps://ClinicalTrials.gov/show/NCT00106626
186891186891A Research Study for Patients With Metastatic Renal Cell CarcinomaCompletedNo Results AvailableCarcinoma, Renal Cell|Neoplasm MetastasisDrug: FK228 (romidepsin)https://ClinicalTrials.gov/show/NCT00106613
186892186892Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)CompletedNo Results AvailableAcute Myelogenous LeukemiaDrug: Pixantrone IV infusionhttps://ClinicalTrials.gov/show/NCT00106600
186893186893Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH – ISR I)CompletedNo Results AvailableCoronary RestenosisDevice: paclitaxel coated balloon catheter (device with drug)https://ClinicalTrials.gov/show/NCT00106587
186894186894A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: Placebo|Drug: tocilizumab [RoActemra/Actemra]https://ClinicalTrials.gov/show/NCT00106574
186895186895Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the KidneyCompletedNo Results AvailableKidney Disease|Diabetic Nephropathy|Glomerulonephritis|ProteinuriaDrug: Spironolactone|Drug: Irbesartanhttps://ClinicalTrials.gov/show/NCT00106561
186896186896A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: tocilizumab [RoActemra/Actemra]|Drug: tocilizumab [RoActemra/Actemra]|Drug: Placebo|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00106548
186897186897A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)CompletedHas ResultsRheumatoid ArthritisDrug: tocilizumab [RoActemra/Actemra]|Drug: Placebo|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00106535
186898186898A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate TherapyCompletedNo Results AvailableRheumatoid ArthritisDrug: Methotrexate|Drug: Placebo|Drug: tocilizumab [RoActemra/Actemra]|Drug: tocilizumab [RoActemra/Actemra]https://ClinicalTrials.gov/show/NCT00106522
186899186899A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaCompletedNo Results AvailableClostridium Enterocolitis|Pseudomembranous ColitisDrug: tolevamer potassium-sodium (GT267-004)https://ClinicalTrials.gov/show/NCT00106509
186900186900A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisCompletedNo Results AvailableDermatitis, AtopicDrug: Protopic|Drug: Corticosteroid|Drug: placebohttps://ClinicalTrials.gov/show/NCT00106496

* Görseller ve İçerik tekif hakkına sahip olabilir